C1QTNF3 and coronary artery disorder: CTRP3 is a potent anti-inflammatory adipokine that inhibits proinflammatory pathways in monocytes and microcells, exerting anti-inflammatory, anti-apoptotic, and cardioprotective effect during development of CAD [15, 16].